Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
Fecha de publicación:
Autores de IDIVAL
Autores ajenos al IDIVAL
- Ramos-Barrón MA
- Gómez-Alamillo C
- Cosme LS
- Gimenez T
- Merino R
- Arias M
Abstract
The contribution of humoral immune response in allograft and xenograft rejection has been clearly demonstrated in recent years. For this reason, inhibition of alloantibody production has become essential in managing transplanted patients. Here, we assessed the effects of the leflunomide derivative FK778 (FK778) in the control of antibody production resulting from semiallogeneic cognate T-B-cell interactions.
Filiaciones
Filiaciones no disponibles
Keywords
- Allograft rejection; Treatment; Transplant